Issue : PJ May 2020 online
Sort by: Newest first Oldest first A-Z Z-A
-
Wholesalers 'almost completely out' of government-supplied PPE, trade body warns
Wholesalers have “almost completely run out” of the personal protective equipment supplied by Public Health England for distribution to community pharmacies during the COVID-19 pandemic, the wholesaler trade body has warned.
-
Manufacturer to move hydroxychloroquine production to the UK to avoid shortages
A manufacturer has announced plans to move production of hydroxychloroquine — currently being trialled as a COVID-19 treatment — to the UK from abroad to combat potential shortages.
-
Immuno-oncology agents for cancer therapy Subscription
Abstract: Until recently, cancer therapy comprised of four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapy. Over the past decade, immuno-oncology (IO) has emerged as a novel and important approach to cancer treatment through the stimulation of the body’s own immune system to kill cancer cells. This newly recognised method of treating cancer is rapidly developing, with many accelerated approvals by the US Food and Drug Administration and European Medicines ...
-
Regulator promises more detail on delayed registration assessment by the end of May 2020
Preregistration trainees have been promised “greater clarity” on the delayed summer pharmacy registration assessment by the end of May 2020.
-
Hydroxychloroquine fails to significantly improve COVID-19 survival rates, studies show
Hydroxychloroquine does not significantly reduce admission to intensive care or improve survival rates in patients hospitalised with pneumonia owing to COVID-19, a study published in the BMJ has found.
-
COVID-19 LATEST: Pharmacy bid for extra COVID-19 funding submitted to government
All the most important developments in the COVID-19 pandemic for pharmacists and their teams, as they happen.
-
Supplies of sedative used for COVID-19 patients diverted from France to avoid potential shortages
Supplies of the sedative midazolam have been diverted from France as a “precaution” to mitigate potential shortages in the NHS caused by COVID-19, the Department of Health and Social Care has said.
-
Remdesivir could be granted conditional marketing authorisation 'in the coming days', says EMA
The investigational antiviral medicine, remdesivir, may be granted a conditional marketing authorisation as a treatment for COVID-19 “in the coming days”, the head of the European Medicines Agency has said.
-
Pharmacist leading coronavirus rapid test project elected as Fellow of Royal Society
A pharmacist who is currently leading a €600,000 project to develop a rapid test for coronavirus infection has been elected as a Fellow of the Royal Society.
-
Video consultation system could be offered to all Scottish community pharmacies Subscription
Community pharmacists in Scotland have begun trialling the ‘NHS Near Me’ video consultation service, and talks have taken place with the Scottish government on how the system could be deployed across community pharmacy.
Show 10 per page20 per page
